Skip to content

Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients

Prevalence Of Hyperhomocysteinemia In Thai CKD Patients And Relationship To Cardiovascular Events: Subgroup Analysis From Thai SEEK Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01391416
Enrollment
98
Registered
2011-07-12
Start date
2010-06-30
Completion date
2011-01-31
Last updated
2011-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Hyperhomocysteinemia

Keywords

Hyperhomocysteinemia, Chronic kidney disease

Brief summary

It is well recognized that patients with chronic kidney disease (CKD) have an increased risk for cardiovascular disease (CVD) and hyperhomocysteinemia appears to be a predictor of future CVD events. Hyperhomocysteinemia has been reported to bo of high prevalence in patients with CKD. The investigators aim to study the prevalence of hyperhomocysteinemia in Thai CKD patients by using Thai Screening and Early Evaluation of Kidney Disease (SEEK) study database and their relationship to CVD.

Detailed description

Ninety eight subjects were sampling from Thai SEEK study database Traditional Traditional risk factors of CVD such as total cholesterol, triglyceride, age, sex, history of smoking and blood pressure levels were examined and recorded. Stored sera of these subjects were analyzed for the total homocysteine (tHcy) level. Analysis of variance was used to evaluate the different of mean tHcy among groups

Interventions

None listed

Sponsors

Bangkok Metropolitan Administration Medical College and Vajira Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* CKD stages 3-4 from Thai SEEK Study

Exclusion criteria

* CKD stage 5

Design outcomes

Primary

MeasureTime frameDescription
Level of Homocysteine3 monthsLevel of homocysteinemia according to each CKD level

Secondary

MeasureTime frameDescription
Association of cardiovascular event to the level of homocysteine3 monthsHugh level of homocysteine will have association with cardiovascular events or not

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026